This study provides evidence that GUSBP11 is involved in CRC progression, identifies the downstream target gene miR-605-3p of GUSBP11, and reveals the mechanism by which GUSBP11 negatively regulates miR-605-3p to affect CRC progression and prognosis. The gene discussed is GUSBP11; the disease is colorectal carcinoma.